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Loss of AKAP1 triggers Drp1 dephosphorylation-
mediated mitochondrial fission and loss in retinal
ganglion cells
Genea Edwards1, Guy A. Perkins2, Keun-Young Kim2, YeEun Kong1, Yonghoon Lee1, Soo-Ho Choi3, Yujia Liu4,
Dorota Skowronska-Krawczyk1, Robert N. Weinreb1, Linda Zangwill1, Stefan Strack 4 and Won-Kyu Ju1
Abstract
Impairment of mitochondrial structure and function is strongly linked to glaucoma pathogenesis. Despite the widely
appreciated disease relevance of mitochondrial dysfunction and loss, the molecular mechanisms underlying
mitochondrial fragmentation and metabolic stress in glaucoma are poorly understood. We demonstrate here that
glaucomatous retinal ganglion cells (RGCs) show loss of A-kinase anchoring protein 1 (AKAP1), activation of calcineurin
(CaN) and reduction of dynamin-related protein 1 (Drp1) phosphorylation at serine 637 (Ser637). These findings
suggest that AKAP1-mediated phosphorylation of Drp1 at Ser637 has a critical role in RGC survival in glaucomatous
neurodegeneration. Male mice lacking AKAP1 show increases in CaN and total Drp1 levels, as well as a decrease in
Drp1 phosphorylation at Ser637 in the retina. Ultrastructural analysis of mitochondria shows that loss of AKAP1 triggers
mitochondrial fragmentation and loss, as well as mitophagosome formation in RGCs. Loss of AKAP1 deregulates
oxidative phosphorylation (OXPHOS) complexes (Cxs) by increasing CxII and decreasing CxIII-V, leading to metabolic
and oxidative stress. Also, loss of AKAP1 decreases Akt phosphorylation at Serine 473 (Ser473) and threonine 308
(Thr308) and activates the Bim/Bax signaling pathway in the retina. These results suggest that loss of AKAP1 has a
critical role in RGC dysfunction by decreasing Drp1 phosphorylation at Ser637, deregulating OXPHOS, decreasing Akt
phosphorylation at Ser473 and Thr308, and activating the Bim/Bax pathway in glaucomatous neurodegeneration.
Thus, we propose that overexpression of AKAP1 or modulation of Drp1 phosphorylation at Ser637 are potential
therapeutic strategies for neuroprotective intervention in glaucoma and other mitochondria-related optic
neuropathies.
Introduction
Primary open-angle glaucoma (POAG) is characterized
by a slow and progressive degeneration of retinal ganglion
cells (RGCs) and their axons, leading to loss of visual
function1. The factors contributing to degeneration of the
RGC and its axon degeneration in POAG are not well
understood. Recent studies have shown that POAG
patients have mitochondrial abnormalities2–7. Evidence
from our group and others indicates that compromised
mitochondrial dynamics, metabolic stress and mitochon-
drial dysfunction by glaucomatous insults such as elevated
intraocular pressure (IOP) and oxidative stress are critical
to RGC loss in experimental glaucoma8–14. Despite the
widely appreciated disease relevance of mitochondrial
dysfunction and loss, the molecular mechanisms under-
lying the impairment of mitochondrial structure and
function in glaucoma are poorly understood.
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A-kinase anchoring protein 1 (AKAP1), a scaffold pro-
tein, is part of the elaborate architecture which binds to
the regulatory subunit of protein kinase A (PKA) along
with other signaling molecules such as Src kinase, protein
phosphatase 1 (PP1), Ca2+-dependent phosphatase calci-
neurin (CaN) and phosphodiesterase 4 (PDE4)15–20. By
recruiting the PKA holoenzyme to the outer mitochon-
drial membrane (OMM), AKAP1 is strategically posi-
tioned to integrate multiple signal transduction cascades,
including cyclic adenosine 3´5´-monophosphate (cAMP)
signaling, in the regulation of mitochondrial shape and
function. AKAP1 facilitates dynamin-related protein 1
(Drp1) phosphorylation and subsequent mitochondrial
elongation. It also increases adenosine triphosphate
(ATP) generation and mitochondrial membrane poten-
tial21,22, and these collective changes are neuroprotec-
tive23,24. Emerging evidence indicates that AKAP1
protects from cerebral ischemic stroke by maintaining
respiratory chain activity, inhibiting Drp1 dependent
mitochondrial fission and superoxide production, and
delaying Ca2+ deregulation24.
Excessive mitochondrial fission-mediated dysfunction
has been implicated in various neurodegenerative diseases
including glaucoma8,11,25,26. Complexes of Drp1 assemble
from the cytosol onto mitochondria at focal sites of
mitochondrial fission27,28. Recent evidence indicates that
posttranslational modifications of Drp1 are linked to
mitochondrial dysfunction-mediated bioenergetic failure,
synaptic injury and neuronal cell death25,29–32. Phos-
phorylation of Drp1 at serine 637 (Ser637) by the cAMP-
dependent PKA promotes mitochondrial fusion, whereas
dephosphorylation by the CaN promotes mitochondrial
fission by decreasing Drp1 activity33–35. Previous studies
showed that inhibition of Drp1 activity prevents mito-
chondrial fission and protects RGCs and their axons in
experimental glaucoma11,36,37. However, it remains
unknown whether AKAP1-mediated Drp1 phosphoryla-
tion at Ser637 plays a critical role in glaucomatous neu-
rodegeneration. Along this line, the existence of AKAP1
in RGCs and its role in glaucoma are completely
unknown.
To address these questions, we investigated AKAP1
protein expression and Drp1 phosphorylation at Ser637 in
retinas from glaucomatous DBA/2J mice, and also eval-
uated the effect of AKAP1 loss in the retina using AKAP1
knockout (AKAP1−/−) mice.
Results
AKAP1 deficiency in glaucomatous RGCs
We examined AKAP1 protein expression in the retina
of a mouse model of glaucoma DBA/2J mice, which
spontaneously develop elevated IOP and glaucomatous
damage with age8,11,38. Control DBA/2J-Gpnmb+/SjJ (D2-
Gpnmb+) was used in which the gene for Gpnmb was
altered to the wild-type sequence by targeted gene
mutation. It is otherwise identical to the DBA/2J mouse
strain, but maintains normal IOP during aging and does
not develop optic nerve axon loss39,40. Our results
demonstrated for the first time that elevated IOP sig-
nificantly decreased AKAP1 protein expression in the
retinas of 10-month-old glaucomatous DBA/2J mice
compared with the retina of age-matched control D2-
Gpnmb+ mice (Fig. 1a). We observed that AKAP1
immunoreactivity was present in high amounts in the
outer plexiform layer (OPL) and ganglion cell layer (GCL)
in D2-Gpnmb+ retina (Fig. 1b). More specifically, AKAP1
immunoreactivity was colocalized with neuronal class III
β-tubulin (TUJ1)-positive RGCs in the GCL of D2-
Gpnmb+ retina. Of interest, however, AKAP1 immunor-
eactivity was decreased in the OPL and TUJ1-positive
RGCs in the GCL of glaucomatous DBA/2J retina
(Fig. 1b, c).
Activation of CaN and dephosphorylation of Drp1 at
Ser637 in glaucomatous retina
AKAP1 binds with two Serine/Threonine phosphatases,
PP1 and CaN41,42. Loss of AKAP1 causes Drp1-mediated
mitochondrial fission and decreases Drp1phsophorylation
at Ser637 in neuronal cells of the brain21,23,24,43,44. More
importantly, AKAP1 protects brain neuronal cells against
cerebral ischemic stroke by inhibiting Drp1-dependent
mitochondrial fission24. Since elevated IOP increased CaN
and total Drp1 protein expression11,45, as well as Drp1
inhibition rescued RGCs and their axons by preserving
mitochondrial integrity in the retina and/or glial lamina of
glaucomatous DBA/2J mice11, we examined the expres-
sion levels of CaN and total Drp1, as well as phosphor-
ylation of Drp1 at Ser637 in the retina of 10-month-old
glaucomatous DBA/2J mice. We observed a significant
increase in CaN protein expression in glaucomatous
DBA/2J retina (Fig. 2a). Consistently, our results showed
an increase in CaN immunoreactivity in RNA-binding
protein with multiple splicing (RBPMS)-positive RGCs as
well as in neurons in the inner nuclear layer (INL) of
glaucomatous DBA/2J retina (Fig. 2b, c). We also
observed a significant increase in total Drp1 protein
expression and a significant dephosphorylation of Drp1
Ser637 in glaucomatous DBA/2J retina (Fig. 2d). Con-
sistently, our results showed an increase in Drp1 immu-
noreactivity in TUJ1-positive RGCs of glaucomatous
DBA/2J retina (Fig. 2e, f). These results suggest that ele-
vated IOP-induced CaN activation is associated with
dephosphorylation of Drp1 at Ser637 in glaucomatous
RGCs, leading to mitochondrial fission11.
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Loss of AKAP1 triggers activation of CaN and
dephosphorylation of Drp1 at Ser637 in the retina
We next used the retinas from 10-month-old mice
lacking AKAP1 (AKAP1−/−)24 and age-matched wild-type
(WT) mice and examined the expression level of CaN.
Following the confirmation of a significant decrease in
AKAP1 gene expression (Fig. 3a), we observed a sig-
nificant increase in CaN protein expression in AKAP1−/−
retina compared with WT retina (Fig. 3b). In addition,
increased CaN immunoreactivity was present in RBPMS-
positive RGCs as well as neurons in the INL in AKAP1−/−
retina (Fig. 3c, d). We further examined expression levels
of AMP-activated protein kinase (AMPK) and Drp1
protein, as well as phosphorylation of AMPK at threonine
172 (Thr172) and Drp1 at Ser637 in AKAP1−/− retina.
There was no significant difference in the phosphorylation
of AMPK at Thr172 between WT and AKAP1−/− retinas,
whereas we observed a significant decrease in total AMPK
protein expression in AKAP1−/− retina (Fig. 4a). Inter-
estingly, we observed a significant increase in total Drp1
protein expression in AKAP1−/− retina (Fig. 4b). Also,
AKAP1−/− retina showed a significant dephosphorylation
of Drp1at Ser637, whereas there was no significant dif-
ference in the phosphorylation of Drp1 at Ser616 between
WT and AKAP1−/− retinas (Fig. 4b). Consistent with this
finding, increased Drp1 immunoreactivity was present in
RBPMS-positive RGCs of AKAP1−/− retina (Fig. 4c, d).
AKAP1 loss causes mitochondrial fission and
mitophagosome formation in RGCs
We further examined the expression levels of optic
atrophy type 1 (OPA1) and mitofusin (Mfn) 1 and 2 in
AKAP1−/− retina and the alteration of mitochondrial
ultrastructure in AKAP1−/− RGC somas. We observed no
significant difference in OPA1 gene expression, but a
significant decrease in total OPA1 protein expression in
AKAP1−/− retina compared with WT (Fig. 5a). More
specifically, expression of the small isoform (80 kDa) of
OPA1 was significantly decreased, whereas there was no
significant difference in the expression of the large iso-
form (100 kDa) of OPA1 in AKAP1−/− retina (Fig. 5a).
We also observed a significant decrease in Mfn1 expres-
sion and a significant increase in Mfn1 protein expression,
whereas there was no significant difference in Mfn2
protein expression in AKAP1−/− retina (Fig. 5a). Using
EM and electron microscope (EM) tomography analyses,
we further assessed changes of mitochondrial ultra-
structure by measuring mitochondrial volume density,
number, cross-sectional area and cristae density in
AKAP1−/− RGC somas. In comparison with WT mice,
representative volumes generated by EM tomography
provided evidence for mitochondrial fission and loss of
mitochondrial mass (Fig. 5b–d). Quantitative analysis
showed significant decreases in mitochondrial volume
density (13 ± 0.7%), and mitochondrial cross-sectional
area (0.14 ± 0.02 μm2), but a significant increase in mito-
chondrial number (0.92 ± 0.06 per μm2) in AKAP1−/−
RGC somas compared with WT (22 ± 2%, mitochondrial
Fig. 1 AKAP1 deficiency in glaucomatous RGCs. a Western blot
analysis for AKAP1 in the retinas of 10-month-old glaucomatous DBA/
2J and age-matched D2-Gpnmb+ mice. b Representative images from
immunohistochemical analyses for AKAP1 (green) and TUJ1 (red) in
the retina of D2-Gpnmb+ and glaucomatous DBA/2J mice.
Arrowheads indicate accumulation of AKAP1 co-labeled with TUJ1 in
RGC somas and arrows indicate TUJ1-labeled axon bundles. Note that
glaucomatous RGCs showed a decrease in AKAP1 protein expression.
Blue color indicates nucleus. c Quantitative analysis for fluorescent
intensity showed a significant decrease in AKAP1 immunoreactivity in
the retina of glaucomatous DBA/2J mice. GCL, ganglion cell layer; IPL,
inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform
layer; ONL, outer nuclear layer. Mean ± SD; n= 3 (a) and n= 10 (c);
*P < 0.05 and ***P < 0.001 (two-tailed unpaired Student’s t test).
Scale bar: 20 μm.
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volume density; 0.20 ± 0.01 μm2, mitochondrial cross-
sectional area; 0.67 ± 0.05 per μm2, mitochondrial num-
ber) (Fig. 5c). However, there was no significant difference
in mitochondrial cristae density, which is the ratio of
cristae membrane surface area divided by the mitochon-
drial outer membrane surface area, between WT and
AKAP1−/− RGC somas (Fig. 5c). Using three-dimensional
(3D) reconstruction of tomographic volumes, we observed
that AKAP1−/− mitochondria are significantly smaller
than the WT mitochondria. Smaller mitochondria should
have fewer cristae, given that cristae shape doesn’t change
a lot, but the density of cristae was about the same
between WT and AKAP1−/− (Fig. 5d). These results
suggest that AKAP1 loss induces an imbalance of mito-
chondrial dynamics by triggering mitochondrial fission
and loss in RGCs. AKAP1 loss promotes mitochondrial
abnormalities and mitophagy in cardiac injury46. Based on
our current findings of mitochondrial fission and loss, we
determined whether AKAP1 loss induces mitophagosome
formation. Indeed, AKAP1 loss significantly enhanced
LC3-II protein expression but decreased p62 protein
expression in AKAP1−/− retina (Fig. 6a). Our results
Fig. 2 CaN-mediated dephosphorylation of Drp1 at S637 in glaucomatous retina. a Western blot analyses for CaN in the retinas of 10-month-
old glaucomatous DBA/2J and age-matched D2-Gpnmb+ mice. b Representative images from immunohistochemical analyses for CaN (green,
arrowheads) co-labeled with RBPMS (red, arrowheads) in RGCs. Note that glaucomatous RGCs showed increases in CaN protein expression. Blue color
indicates nucleus. c Quantitative analysis for fluorescent intensity showed a significant increase in CaN immunoreactivity in the retina of
glaucomatous DBA/2J mice. d Western blot analyses for total Drp1 and phospho-Drp1 Ser637 in the retinas of glaucomatous DBA/2J and age-
matched D2-Gpnmb+ mice. e Representative images from immunohistochemical analyses for total Drp1 (green, arrowheads) co-labeled with
TUJ1 (red, arrowheads) in RGCs. Note that glaucomatous RGCs showed increases in total Drp1 protein expression. Blue color indicates nucleus.
f Quantitative analysis for fluorescent intensity showed a significant increase in Drp1 immunoreactivity in the retina of glaucomatous DBA/2J mice.
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Mean ± SD; n= 3 (a, d)
and n= 10 (c, f); **P < 0.01 and ***P < 0.001 (two-tailed unpaired Student’s t test). Scale bar: 20 μm.
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Fig. 3 CaN expression in AKAP1−/− retina. a Quantitative RT-PCR analysis for AKAP1 in the retinas of AKAP1−/− and WT mice. b Western blot
analysis for CaN in the retinas of AKAP1−/− and WT mice. c Representative images from immunohistochemical analyses for CaN (green, arrowheads)
co-labeled with RBPMS (red, arrowheads) in RGCs. Note that glaucomatous RGCs showed increases in CaN protein expression in the GCL and INL.
Blue color indicates nucleus. d Quantitative analysis for fluorescent intensity showed a significant increase in CaN immunoreactivity in the retina of
AKAP1−/− mice. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Mean
± SD; n= 3 or 4 (a, b) and n= 10 (d); **P < 0.01 and ***P < 0.001 (two-tailed unpaired Student’s t test). Scale bar: 20 μm.
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showed strong LC3 immunoreactivities in RGC somas
and axons in the GCL of AKAP1−/− mice (Fig. 6b).
Notably, segmented volumes from 3D tomographic
reconstructions using EM tomography revealed examples
of degraded mitochondria with severe cristae depletion
that were engulfed in mitophagosomes in RGC soma of
AKAP1−/− mice (Fig. 6c–j).
AKAP1 loss results in OXPHOS dysfunction and induces
oxidative stress in the retina
Since AKAP1 deletion increased superoxide production
in primary hippocampal and cortical neurons in response
to glutamate excitotoxicity as well as resulted in OXPHOS
complex (Cx) II dysfunction24, we determined whether
loss of AKAP1 alters OXPHOS Cxs and induces oxidative
stress in the retina. We further observed that AKAP1 loss
significantly increased OXPHOS Cx II but decreased
OXPHOS Cx III–V protein expression in AKAP1−/−
retina (Fig. 7a). However, there was no significant differ-
ence in OXPHOS Cx I protein expression between WT
and AKAP1−/− retinas (Fig. 7a). We observed a significant
increase in superoxide dismutase 2 (SOD2) protein
expression in AKAP1−/− retina (Fig. 7b). We also observed
that SOD2 protein expression was increased in the inner
retina, including RGCs in the GCL, of AKAP1−/− mice
(Fig. 7c, d). These results suggest that AKAP1 loss com-
promises OXPHOS and may contribute to oxidative stress.
AKAP1 loss inactivates Akt and activates Bim/Bax pathway
in the retina
We examined the expression levels of Akt protein
expression, and Akt phosphorylation at serine 473
(Ser473) and threonine 308 (Thr308) in AKAP1−/− retina.
We observed a significant increase in total Akt protein
expression but a significant dephosphorylation of Akt at
Ser473 and Thr308 in AKAP1−/− retina (Fig. 8a). Con-
sistently, our results showed that Akt immunoreactivity
was increased in the INL and GCL of AKAP1−/− retina
(Fig. 8b, c). More specifically, increased Akt immunor-
eactivity was prominent in Brn3a-positive RGCs of
AKAP1−/− mice (Fig. 8b, c). Because Akt inactivation is
associated with Bim/Bax activation and intrinsic apoptotic
cell death47,48, we further determined whether AKAP1
loss activates Bim/Bax in the retina. We observed sig-
nificant increases in Bim and Bax protein expression in
AKAP1−/− retina (Fig. 8d). In addition, we observed that
Bax immunoreactivity was increased in the GCL of
AKAP1−/− retina (Fig. 8d). More specifically, increased
Bax immunoreactivity was prominent in RBPMS-positive
RGCs of AKAP1−/− mice (Fig. 8e, f).
Discussion
We here demonstrated for the first time that RGCs
showed AKAP1 immunoreactivity in D2-Gpnmb+ mice
and elevated IOP triggered loss of AKAP1 in
Fig. 4 Phosphorylation of AMPK at Thr172 and Drp1 at Ser637 in AKAP1−/− retina. a Western blot analysis for AMPK and phospho-AMPK
Thr172 in the retinas of AKAP1−/− and WT mice. bWestern blot analysis for total Drp1, phospho-Drp1 Ser637 and phospho-Drp1 Ser616 in the retinas
of AKAP1−/− and WT mice. c Representative images from immunohistochemical analyses for total Drp1 (green, arrowheads) co-labeled with RBPMS
(red, arrowheads) in RGCs. Note that glaucomatous RGCs showed an increase in total Drp1 protein expression in RGCs. Blue color indicates nucleus.
d Quantitative analysis for fluorescent intensity showed a significant increase in Drp1 immunoreactivity in the retina of AKAP1−/− mice. GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Mean ± SD; n= 3 or 6 (a)
and n= 10 (d); *P < 0.05 (two-tailed unpaired Student’s t test). Scale bar: 20 μm.
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glaucomatous RGCs. In addition, elevated IOP increased
CaN and total Drp1 levels in glaucomatous RGCs. It also
impaired Drp1 phosphorylation at Ser637 in glaucoma-
tous retina. These results suggest that AKAP1 and Drp1
phosphorylation at Ser637 have critical roles in RGC
mitochondria and survival against glaucomatous damage.
We also observed that loss of AKAP1 increased CaN and
total Drp1 levels in RGCs, and compromised Drp1
phosphorylation at Ser637 in the retina, leading to mito-
chondrial fission and loss, and mitophagosome formation
in RGCs. In addition, loss of AKAP1 resulted in OXPHOS
dysfunction, as well as Akt inactivation and Bim/Bax
activation; these effects contribute to glaucomatous
neurodegeneration.
Impairment of mitochondrial dynamics is critically
involved in the degeneration of glaucomatous RGCs and
their axons8,9,11,36, and inhibition of Drp1 rescues RGCs
and their axons by preserving mitochondrial integrity in
experimental glaucoma11,36. Our previous study demon-
strated that elevated IOP showed a significant increase in
total Drp1 level, while it did not alter phosphorylation of
Drp1 at Ser616 in glaucomatous retina11; these effects
Fig. 5 Mitochondrial fission in AKAP1−/− RGC somas. a Quantitative RT-PCR analyses for OPA1 and Mfn1 and Western blot analysis for total OPA1
(L-OPA1 & S-OPA1), and Mfn1 and 2 in the retinas of AKAP1−/− and WT mice. b–d EM and EM tomography analyses for mitochondrial fission and loss
in AKAP1−/− RGC somas. b 1.6-nm thick slices through the middle of tomographic volumes of WT RGC somas show an abundance of larger
mitochondria. In contrast, the mitochondria are smaller with a greater number in AKAP1−/− RGC somas, but show no alteration of cristae
architecture. c Quantitative analyses of mitochondrial volume density, number and cross-sectional area and cristae density in WT and AKAP1−/− RGC
somas. Note that AKAP1−/− RGC somas show significant loss of mitochondrial mass and cross-sectional area, and a significant increase in
mitochondrial number. However, there was no significant difference in cristae density of AKAP1−/− RGC somas. d Top view of the surface-rendered
volume showing three adjacent mitochondria from a WT tomographic volume (left) and an AKAP1−/− volume (right). Comparing the side view with
the top view provides perspective on the distribution of the predominantly tubular cristae (in an assortment of colors) and reveals substantial
heterogeneity of cristae size. The mitochondrial outer membranes were made translucent to better visualize the cristae. The number of cristae in
each mitochondrion is indicated. Mean ± SD (a) and Mean ± SEM (c); n= 3 (a), n= 11 (mitochondrial volume, number and cristae density for WT and
AKAP1−/−, c) and n= 22 or 39 (mitochondrial size for WT or AKAP1−/−, c); *P < 0.05 and **P < 0.01 (two-tailed unpaired Student’s t test). Scale bars:
200 nm.
Edwards et al. Cell Death and Disease          (2020) 11:254 Page 7 of 15
Official journal of the Cell Death Differentiation Association
suggest that elevated IOP-mediated mitochondrial fission
activity is not dependent on Drp1 phosphorylation at
Ser616 in glaucomatous RGC degeneration. Hence, our
novel finding that glaucomatous RGCs lacking AKAP1
trigger CaN-mediated dephosphorylation of Drp1 at
Ser637 suggest an important rationale to further investi-
gate the impact of AKAP1 loss, mitochondrial fission and
its related signaling pathway in RGCs.
AKAP1 is an important regulator of mitochondrial
function by PKA anchoring and Drp1 phosphorylation at
Ser637, and overexpression of AKAP1 is neuroprotective
in neuronal cells against the mitochondrial toxin
rotenone20,21,23,24,43. Emerging evidence showed that mice
lacking AKAP1 exhibit increased infarct size following
transient cerebral ischemia as well as increased Drp1
localization to mitochondria from the forebrain tissues
and decreased Drp1 phosphorylation at Ser63724. Our
findings of enhanced CaN-mediated Drp1 phosphoryla-
tion at Ser637, and extensive mitochondrial fission and
loss in the retina of AKAP1−/− mice suggest that AKAP1
loss directly contributes to Drp1 phosphorylation-
dependent mitochondrial fission and loss in glaucoma-
tous RGCs. This notion is also supported by the evidence
of increasing LC3-II and decreasing p62 levels, as well as
Fig. 6 Mitophagosome formation in AKAP1−/− RGC somas. a Western blot analyses for LC3 and p62 in the retinas of AKAP1−/− and WT mice.
b Representative images from immunohistochemical analyses for LC3 (green) co-labeled with TUJ1 (red) in RGCs and their axons. Note that LC3
immunoreactivity was localized in RGC somas (arrowheads) and their axons (arrows) in WT and AKAP1−/− retina. Blue color indicates nucleus. GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Scale bar, 20 μm. c–j EM
tomography and 3D reconstruction analysis. c A 1.6 nm thick slice through the tomographic volume of the RGC showing an autophagosome with a
degenerating mitochondrial fragment inside. A mitochondrion is nearby with a strand of ER positioned in between the autophagosome and
mitochondrion. ER is typically involved with mitochondrial fission. The double membrane of the autophagosome is only partially visualized and so is
indicated by white arrowheads on opposite sides. For comparison, the double membrane of the mitochondrial periphery is indicated by black
arrowheads on opposite sides to emphasize that the spacing between individual autophagosomal membranes is about the same as the spacing
between individual mitochondrial peripheral membranes, as it should be. Labels: A, autophagosome; M, mitochondrion; PM, RGC plasma membrane;
ER, endoplasmic reticulum strand. Scale = 200 nm. d Another slice through the RGC volume showing a small stretch of clearly separated
components of the autophagosomal double membrane (white arrowheads). For comparison, the spacing of the mitochondrial double membrane is
indicated by the black arrowheads. e A third slice through the RGC volume that best shows the double membrane of the mitochondrial fragment
(white arrowheads) inside the autophagosome. Perhaps the reason that less than half the mitochondrial double membrane is seen is because it was
being degraded at the time the tissue was fixed. The spacing between the individual membranes of the fragment is the same as the spacing
between the individual membranes of the mitochondrion (black arrowheads). f Side view with the mitophagosome membrane made transparent to
see the engulfed mitochondrion. g Side view with the outer mitochondrial membrane made transparent to see the two fragments of the inner
boundary membrane (IBM) and the one crista that remain. h Top view showing the crista and right-hand portion of the IBM inside the
mitochondrion, which is inside the mitophagosome. i, j An oblique view with the mitophagosome and outer mitochondrial membranes made
transparent to see the crista and two IBM fragments. Note that mitochondria in the AKAP1−/− RGC soma demonstrate autophagosome/
mitophagosome formation. Mean ± SD; n= 3 or 4 (a); *P < 0.05 and **P < 0.01 (two-tailed unpaired Student’s t test). Scale bar: 500 nm.
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mitophagosome formation that contains degrading
mitochondria in RGC somas of AKAP1−/− mice. In
addition, it is supported by the evidence of our previous
report showing autophagosome/mitophagosome forma-
tion in RGC axons of glaucomatous DBA/2J mice11.
AMPK is a nutrient and energy sensor that maintains
energy homeostatsis49 and mediates mitochondrial fission
in response to energy stress50. It has been reported that
there was evidence of AMPK activation by increasing
AMPK phosphorylation at Thr172 in the retina and optic
nerve in glaucomatous DBA/2J mice14,51. Also, it has been
proposed that AMPK uncouples PKA from D-AKAP1
(AKAP140/149 and other splice variants AKAP121,
sAKAP84) to promote mitochondrial fission and mito-
phagy52. Furthermore, AMPK is associated with the reg-
ulation of Drp1 phosphorylation53,54. In the current study,
our findings showed no significant evidence of AMPK
activation, suggesting that AKAP1 loss may not directly
contribute to AMPK activation in the retina. Because
energy stress activates AMPK14,55, it is also possible that
AKAP1 loss may not trigger an excessive energy stress
and substantial energy deficit in the retina. Consistent
with this notion, our results showed that the level of
dephosphorylation of Drp1 Ser637 in AKAP1−/− retina
was relatively modest compared to the level of depho-
sphorylation of Drp1 Ser637 in glaucomatous retina.
Hence, our results intriguingly raise the possibility that
combined induction of both AMPK activation and
AKAP1 loss may exacerbate mitochondrial fission and
loss in glaucomatous RGCs and their axons, leading to the
promotion of energy crisis and cell death. We believe that
further studies will be required to determine the rela-
tionship between AMPK activation and AKAP1 loss in
glaucomatous RGCs.
An increase in LC3-II generates autophagosomes, but
does not guarantee autophagic degradation. If, however,
the amount of LC3-II further accumulates in the presence
of lysosomal protease inhibitors, this would indicate
enhancement of autophagic flux56. On the other hand, the
protein expression level of p62/SQSTM1, a polyubiquitin
binding protein, serves as an autophagic receptor and is a
good indicator of autophagic flux57–59. Also, p62 protein
expression has been used as an autophagic marker with
LC3-II60. Although the p62 level alone is not indicative of
activation of autophagy, p62 is also a marker for the
degradation phase of autophagosomes and has a lot of
functions beyond autophagy59. In the current study, our
findings showed that loss of AKAP1 increased LC3-II
protein expression but decreased p62 protein expression
in AKAP1−/− retina. Intriguingly, AKAP1−/− heart
reduced p62 protein expression and enhanced mitophagy
and apoptosis46. Collectively, our results suggest that the
increased LC3-II and decreased p62 contribute to the
induction of autophagy/mitophagy in AKAP1−/− retina.
Fig. 7 OXPHOS dysfunction and oxidative stress in AKAP1−/−
retinas. a Western blot analyses for OXPHOS Cxs in the retinas of
AKAP1−/− and WT mice. b Western blot analyses for SOD2 in the retinas
of AKAP1−/− and WT mice. c Representative images from
immunohistochemical analyses for SOD2 (green, arrowheads) co-labeled
with Brn3a (red, arrowheads) in the retina. Note that the AKAP1−/− retina
shows increases in SOD2 protein expression in the inner retinal layer
compared with WT retina. Blue color indicates nucleus. d Quantitative
analysis for fluorescent intensity showed a significant increase in SOD2
immunoreactivity in the retina of AKAP1−/−mice. GCL, ganglion cell layer;
IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform
layer; ONL, outer nuclear layer. Mean ± SD; n= 4 or 10 (a), n= 4 (b) and
n= 10 (d). *P< 0.05, **P< 0.01 and ***P< 0.001 (two-tailed unpaired
Student’s t test). Scale bar: 20 μm.
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Hence, we raise the possibility that loss of AKAP1 may
not only induce autophagosome/mitophagosome forma-
tion, but also trigger an increase in autophagic flux and
degradation in RGCs. Also, whether this autophagic/
mitophagic process is a compensatory or pathological
pathway in AKAP1−/− retina should be considered in
future studies.
A previous study presented the notion that AKAP1
regulates mitochondrial dynamics by posttranslational
modifications, but levels of Drp1, OPA1, and Mfn2 were
unaltered in total forebrain homogenates from AKAP1−/−
mice24. Of interest, however, we observed a decrease in
total OPA1, but an increase in total Drp1 and Mfn1 in the
retina of AKAP1−/− mice. Inner membrane-anchored
Fig. 8 Akt inactivation and Bim/Bax activation in AKAP1−/− retinas. a Western blot analyses for Akt, phospho-Akt Ser473 and phospho-Akt
Thr308 in the retinas of AKAP1−/− and WT mice. b Representative images from immunohistochemical analyses for Akt (green, arrowheads) co-
labeled with Brn3a (red, arrowheads) in the retina. Note that AKAP1−/− retinas show increases in Akt protein expression in the INL and GCL compared
with WT retinas. Blue color indicates nucleus. c Quantitative analysis for fluorescent intensity showed a significant increase in Akt immunoreactivity in
the retina of AKAP1−/− mice. d Western blot analyses for Bim and Bax in the retinas of AKAP1−/− and WT mice. e Representative images from
immunohistochemical analyses for Bax (green, arrowheads) co-labeled with RBPMS (red, arrowheads) in the retina. Note that AKAP1−/− retinas show
increases in Bax protein expression in the GCL compared with WT retinas. Blue color indicates nucleus. f Quantitative analysis for fluorescent intensity
showed a significant increase in Bax immunoreactivity in the retina of AKAP1−/− mice. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner
nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Mean ± SD; n= 3 or 4 (a, d) and n= 10 (c, f). *P < 0.05, **P < 0.01 and ***P < 0.001
(two-tailed unpaired Student’s t test). Scale bar: 20 μm.
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long OPA1 (L-OPA1) undergoes proteolytic cleavage
resulting in short OPA1 (S-OPA1)61. Cells contain a
mixture of L-OPA1, required for mitochondrial fusion
and S-OPA, which facilitate mitochondrial fission under
normal conditions. Disruption of this balance in times of
stress, results in mitochondrial fragmentation61. Thus,
these unexpected, but important results propose the
possibility that AKAP1 may contribute to the regulation
of mitochondrial dynamics not only by posttranslational
modifications, but also by alteration of fusion/fission
protein expression in the retina. Future studies will be
needed to clarify the molecular mechanisms underlying
the alteration of fusion/fission proteins in the retina
lacking AKAP1.
Emerging evidence showed that AKAP1 deletion
resulted in OXPHOS Cx II dysfunction in neuronal
cells24. OXPHOS Cx II is a source of the mitochondrial
reserve respiratory capacity that is regulated by metabolic
sensors and promotes cell survival against hypoxia. In the
present study, the observation that increasing OXPHOS
Cx II, but decreasing OXPHOS Cxs III-V activities trig-
gered by loss of AKAP1 in the retina implies that AKAP1
plays a critical role in OXPHOS function in RGCs.
Moreover, increasing OXPHOS Cx II activity may be an
important endogenous compensatory defense mechanism
in response to oxidative stress. Further, this imbalance of
OXPHOS Cxs suggests another possibility that AKAP1
loss may contribute to an increase in ROS production and
decrease in ATP production in the retina that are pre-
viously reported in pressure and/or oxidative stress-
induced RGC degeneration11. In particular, association
of POAG with polymorphism of mitochondrial cyto-
chrome c oxidase subunit 1 of OXPHOS Cx IV suggests a
potential role of abnormal OXPHOS-mediated mito-
chondrial dysfunction in glaucoma pathogenesis3,4.
Therefore, these results collectively suggest that AKAP1
loss in glaucomatous retina contributes to OXPHOS
dysfunction that is associated with metabolic and oxida-
tive stress by increasing ROS production and decreasing
ATP production, leading to RGC death during glauco-
matous neurodegeneration.
Loss of AKAP1 inactivates Akt signaling and increases
apoptosis in cardiac dysfunction62,63. The Akt pathway
controls the expression of apoptosis-related genes
through transcription factors such as FoxO (FoxO1 and
FoxO3a)64,65 and Akt activation promotes cell survival by
inhibiting the FoxO3a/Bim/Bax pathway48,64,65. The pro-
apoptotic Bcl-2 homology domain 3-only protein Bim
induces apoptosis, primarily through its increased binding
activity toward multiple pro-survival Bcl-2-like proteins,
whose dissociations activate Bak and Bax66,67. In addition,
Bax-mediated mitochondrial outer membrane permeabi-
lization is an important pathophysiological mechanism for
metabolic dysfunction and cell death68,69, and Bax
activation plays a critical role in mitochondrial
dysfunction-mediated RGC degeneration11,12. Because
Drp1 contributes to Bax oligomerization, mitochondrial
fission and the cellular apoptotic pathway70–72, increased
total Drp1 and Bax levels in AKAP1−/− retinas suggest
that AKAP1 loss may contribute to Drp1-mediated Bax
oligomerization, leading to mitochondrial fission. Recent
evidence from our group and others indicated that acti-
vation of the cAMP/PKA pathway promotes RGC survi-
val48,73–75 and that AKAP1-mediated neuroprotection
requires PKA anchoring and Drp1 phosphorylation at
Ser63721,23,24,43,76. In this regard, our observation that
dephosphorylation of Akt at Ser473 and SerT308 in
AKAP1−/− retinas, and activation of the Bim/Bax pathway
raise the possibility that AKAP1 may be critical to RGC
protection by modulating the Akt/Bim/Bax pathway
against glaucomatous damage. Future studies will be
necessary to examine whether overexpression of AKAP1
rescues RGCs by promoting Drp1 phosphorylation at
S637, maintaining metabolic activity, activating the Akt
pathway and inhibiting the Bim/Bax pathway.
In summary, our results represent the first direct evi-
dence of a Drp1 phosphorylation-mediated mitochondrial
pathogenic mechanism that leads to mitochondrial fission
and metabolic dysfunction in glaucomatous RGC degen-
eration. Also, we provide evidence for the first time that
AKAP1 loss-mediated CaN activation and Drp1 depho-
sphorylation at Ser637 result in mitochondrial fission,
mitophagosome formation, OXPHOS dysfunction and
oxidative stress, as well as Akt inactivation and Bim/Bax
activation in RGCs. Therefore, we propose overexpression
of AKAP1 and modulation of Drp1 phosphorylation at
Ser637 as therapeutic strategies for neuroprotective
intervention in glaucoma and other mitochondria-related
optic neuropathies.
Materials and methods
Animals
Adult female DBA/2J and D2-Gpnmb+ mice (The
Jackson Laboratory), and adult male WT and AKPA1−/−
mice were housed in covered cages, fed with a standard
rodent diet ad libitum, and kept on a12 h light/12 h dark
cycle. Animals were assigned randomly to experimental
and control groups. The following PCR primers were used
to determine AKAP1 genotype: GGAGGCGATCACAG
CAACAACCG (R), ATACAGAAGCAGATCACTCAG
GAGG (F-WT), CAGTCCCAAGGCTCATTTCAGGCC
(F-KO)24. To investigate the effect of IOP elevation, 20 10
month-old DBA/2J and 10 age-matched D2-Gpnmb+
mice were used. To investigate the effect of AKAP1 loss,
10 10 month-old AKAP1−/− and 10 age-matched WT
mice were used. All procedures concerning animals were
in accordance with the Association for Research in Vision
and Ophthalmology Statement for the Use of Animals in
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Ophthalmic Vision Research and under protocols
approved by Institutional Animal Care and Use Com-
mittee at the University of California, San Diego.
Tissue preparation
Mice were anesthetized by an intraperitoneal (IP)
injection of a cocktail of ketamine (100 mg/kg, Ketaset;
Fort Dodge Animal Health) and xylazine (9 mg/kg,
TranquiVed; VEDCO Inc.) prior to cervical dislocation.
The investigators were not blinded during the tissue and
data collection from the mice. Blinding was used during
data analysis. For immunohistochemistry, the retinas were
dissected from the choroids and fixed with 4% paraf-
ormaldehyde (Sigma-Aldrich) in phosphate buffered sal-
ine (PBS, pH 7.4) for 2 h at 4 °C. Retinas were washed
several times with PBS then dehydrated through graded
levels of ethanol and embedded in polyester wax. For
Western blot and PCR analyses, extracted retinas were
immediately used.
Western blot analyses
Harvested retinas (n= 4 retinas/group) were homo-
genized for 1 min on ice with a modified RIPA lysis buffer
(150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 1 mM
DTT, 0.5% sodium deoxycholate and 50mM Tris-Cl, pH
7.6), containing complete protease inhibitors. The lysates
were then centrifuged at 15,000 g for 15 min and protein
amounts in the supernatants were measured by the
Bradford assay. Proteins (10–20 μg) were separated by
SDS/PAGE and electrotransferred to polyvinylidene
difluoride membranes (GE Healthcare Bio-Science). The
membranes were blocked with 5% non-fat dry milk and
PBS/0.1% Tween-20 (PBS-T) for 1 h at room temperature
and incubated with primary antibodies overnight at 4 °C.
Primary antibodies used were mouse monoclonal anti-
Actin antibody (1:20,000; Millipore; Cat#, MAB1501),
rabbit monoclonal anti-AKAP1 (1:1000; Cell Signaling;
Cat# 5203), rabbit polyclonal anti-Akt antibody (1:5000;
Cell Signaling; Cat# 92725), mouse monoclonal anti-
phospho-Akt Ser473 antibody (1:100, Cell Signaling; Cat#
9271), rabbit monoclonal anti-phospho-Akt Thr308
antibody (1:1000, Cell Signaling; Cat# 4056), rabbit poly-
clonal anti-AMPKα1/2 antibody (1:1000, Santa Cruz
Biotechnology; Cat# sc25792), rabbit monoclonal anti-
AMPKα Thr172 antibody (1:1000, Cell Signaling Cat#
2535), mouse monoclonal anti-Bax antibody (6A7; 1:500;
Santa Cruz Biotechnology; Cat# sc-23959), rabbit poly-
clonal anti-Bim antibody (1:100, Santa Cruz Biotechnol-
ogy; Cat# sc-8265), mouse monoclonal anti-CaN antibody
(1:200, BD Bioscience; Cat# 610259), mouse monoclonal
anti-Drp1 antibody (1:1000; BD Biosciences; Cat#
611113), rabbit polyclonal phospho-Drp1 Ser637 antibody
(1:750; Cell Signaling; Cat# 4867), rabbit polyclonal
phospho-Drp1 Ser616 antibody (1:750; Cell Signaling;
Cat# 3455), rabbit polyclonal anti-LC3 antibody (1:2000;
MBL International; Cat# PM036), mouse monoclonal
anti-Mfn1 antibody (1:20000; Abcam; Cat# ab57602),
mouse monoclonal anti-Mfn2 antibody (1:2000; Abcam;
Cat# ab56889), mouse monoclonal anti-OPA1 antibody
(1:2000; BD Biosciences; Cat# 612607), rat/mouse
monoclonal anti-OXPHOS Cx Cocktail Kit (1:1000;
Invitrogen; Cat# 458099), rabbit polyclonal p62 antibody
(1:1000; MBL International; Cat# PM045) and rabbit
polyclonal anti-SOD2 antibody (1:5000; Santa Cruz; Cat#
sc-30080). The membranes were washed several times
with PBS-T then incubated with peroxidase-conjugated
goat anti-mouse or rabbit IgG (1:1000-7000; Bio-Rad;
Cat# 1721011 or 1706515) for 1 h at room temperature
and developed using an enhanced chemiluminescence
substrate system. The images were captured and quanti-
fied using the ImageQuant™ LAS 4000 system (GE
Healthcare Bio-Science) and band densities were nor-
malized to that of actin, total Drp1, total Akt, or
total AMPK.
Immunohistochemistry
Immunohistochemical staining of 7 μm-thick wax sec-
tions of full-thickness retina was performed. Sections
from wax blocks from each group (n= 4 retinas/group)
were used for immunohistochemical analysis. Primary
antibodies included rabbit monoclonal anti-AKAP1 anti-
body (1:100, Cell Signaling; Cat# 5203), rabbit polyclonal
anti-Akt antibody (1:100, Cell Signaling; Cat# 92725),
mouse monoclonal anti-Bax antibody (6A7; 1:50, Santa
Cruz Biotechnology; Cat# sc-23959), goat polyclonal anti-
Brn3a antibody (1:500, Santa Cruz Biotechnology; Cat#
sc-23959), mouse monoclonal anti-CaN (1:200, BD
Bioscience; Cat# 610259), mouse monoclonal anti-Drp1
antibody (1:25; BD Biosciences; Cat# 611113), rabbit
polyclonal anti-Drp1 (1:50, Santa Cruz Biotechnology,
Cat# sc-32898), rabbit polyclonal anti-LC3 antibody
(1:2000; MBL International); Cat# PM036, rabbit poly-
clonal anti-RBPMS (1:300, Novus; Cat# NBP2-20112),
rabbit polyclonal anti-SOD2 antibody (1:300, Santa Cruz
Biotechnology; Cat# sc-30080) and mouse monoclonal
anti-TUJ1 (1:300, BioLegend; Ct# 801202). To prevent
non-specific background, tissues were incubated in 1%
bovine serum albumin/PBS for 1 h at room temperature
before incubation with the primary antibodies for 16 h at
4 °C. After several washing steps, the tissues were incu-
bated with the secondary antibodies, Alexa Fluor 488 or
568 dye-conjugated donkey anti-mouse IgG (1:100, Invi-
trogen; Cat# R37114 or A10037), Alexa Fluor 488 or 568
dye-conjugated donkey anti-rabbit IgG (1:100, Invitrogen;
Cat# R37118 or A10042) and Alexa Fluor 568 dye-
conjugated donkey anti-goat IgG (1:100, Invitrogen; Cat#
A11057) for 4 h at 4 °C and subsequently washed with
PBS. The sections were counterstained with the nucleic
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acid stain Hoechst 33342 (1 μg/mL; Invitrogen) in PBS.
Images were acquired with confocal microscopy (Olym-
pus FluoView1000; Olympus, Tokyo, Japan). Each target
protein fluorescent integrated intensity in pixel per area
was measured using the ImageJ software77–79. All imaging
parameters remained the same and were corrected with
the background subtraction.
RT-PCR and quantitative real-time RT-PCR
Total RNA was isolated from retinas of each group (n=
4 retinas/group) using the Absolutely RNA Miniprep Kit
(Stratagene), according to the manufacturer’s protocol as
previously described48. cDNAs were synthesized from
total RNAs with iScript cDNA Synthesis Kit (Bio-Rad)
according to the manufacturer’s protocols. Reverse
Transcription (RT)-PCR was performed with cDNAs
synthesized from 1 μg of the total RNA of each group as a
template and specific primers for: AKAP1, CTGCCAG
TCAGTACTCAGCC (F), CTTTGGCACCTCGATCTCC
C (R), OPA1, CATCTACCTTCCAGCTGCCC (F),
TCTCCTCCTTCACAGCCTCC (R), and Mfn1, GTTTT
CCCTGGGCTGGTCTT (F), TTTTCCAAATCACGC
CCCCA (R). For the quantification of the relative mRNA
expressions of each group, real-time PCR was carried out
using the MX3000P real-time PCR system (Stratagene) as
follows. cDNAs were amplified using SSO Adv. Universal
SYBR Green SuperMix (Bio-Rad) and the specific primers
for 40 cycles (95 °C for 5 min, and 40 cycles (95 °C for 30 s,
60 °C for 30 s, and 72 °C for 30 sec)). Output data were
obtained as Ct values and the differential mRNA expres-
sion of the target genes among groups was calculated
using the comparative Ct method. GAPDH mRNA, an
internal control, was amplified along with the target gene,
and the Ct value of GAPDH was used to normalize the
expression of the target gene.
Transmission electron microscopy
For conventional EM, two eyes from each group (n= 2
mice) were fixed via cardiac perfusion with 2% paraf-
ormaldehyde, 2.5% glutaraldehyde (Ted Pella, Redding,
CA) in 0.15M sodium cacodylate (pH 7.4, Sigma) solution
at 37 °C and placed in pre-cooled fixative of the same
composition on ice for 1 h. The following procedure was
used to optimize mitochondrial structural preservation
and membrane contrast. The retinas were dissected in a
solution of 0.15M sodium cacodylate plus 3 mM calcium
chloride (pH 7.4) on ice and then post-fixed with a 1%
osmium tetroxide, 0.8% potassium ferrocyanide, 3 mM
calcium chloride in 0.1M sodium cacodylate solution (pH
7.4) for 1 h, washed with ice-cold distilled water, post-
stained with 2% uranyl acetate solution at 4 °C, dehy-
drated using graded ethanols, and embedded in Durcupan
resin (Fluka). A similar procedure was used for cultured
primary RGCs from each group. Ultrathin (70 nm)
sections were poststained with uranyl acetate and lead salt
solutions and evaluated using a JEOL 1200FX transmis-
sion EM operated at 80 kV. Images were recorded on film
at ×8000 magnification. The negatives were digitized at
1800 dpi using a Nikon Cool scan system, giving an image
size of 4033 × 6010 pixel array and a pixel resolution of
1.77 nm. For quantitative analysis, the number of mito-
chondria was normalized to the total area occupied by
axons in each image, which was measured using ImageJ
(http://rsb.info.nih.gov/ij/). Mitochondrial lengths were
measured with ImageJ. The mitochondrial volume den-
sity, defined as the volume occupied by mitochondria
divided by the volume occupied by the axoplasm, was
estimated using stereology as follows. A 112 × 112 square
grid (112 × 112 chosen for ease of use with Photoshop)
was overlaid on each image loaded in Photoshop (Adobe
Systems Inc.), and mitochondria and axoplasm lying
under intercepts were counted. The relative volume of
mitochondria was expressed as the ratio of intercepts
coinciding with this organelle relative to the intercepts
coinciding with axoplasm.
Electron microscope tomography
Sections of retina tissues from each group were cut at a
thickness of 400 nm. For each reconstruction, a double-
tilt series of images at one-degree tilt increment was
collected with an FEI titan hibase electron microscope
operated at 300 kV. Images were recorded with a Gatan
4Kx4K CCD camera. The magnification was ×11,000 and
the pixel resolution was 0.81 nm. The IMOD package was
used for alignment, reconstruction and volume segmen-
tation. Volume segmentation was performed by manual
tracing of membranes in the planes of highest resolution
with the Drawing Tools and Interpolator plug-ins80. The
mitochondrial reconstructions and surface-rendered
volumes were visualized using 3DMOD. Measurements
of mitochondrial outer, inner boundary, and cristae
membrane surface areas and volumes were made within
segmented volumes using IMODinfo. These were used to
determine the cristae density, defined as the ratio: sum of
the cristae membrane surface areas divided by the mito-
chondrial outer membrane surface area. Movies of the
tomographic volume were made using IMODmovie.
Statistical analyses
Data were shown as mean ± S.D. Comparison of
experimental conditions was evaluated using the two-
tailed unpaired Student’s t test between groups. P < 0.05
was considered to be statistically significant.
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